Roivant Sciences Ltd (ROIV)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Disposal | 200,000 | $36.31 |
| Oct 28, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Disposal | 200,000 | $36.59 |
| Oct 23, 2026 | EPPERLY, MELISSA B, | Director | Common Shares | Acquisition | 513 | $0 |
| Oct 23, 2026 | EPPERLY, MELISSA B, | Director | Common Shares | Disposal | 116 | $36.49 |
| Oct 23, 2026 | MOMTAZEE, JAMES C | Director | Common Shares | Acquisition | 383 | $0 |
| Oct 23, 2026 | MOMTAZEE, JAMES C | Director | Common Shares | Disposal | 77 | $36.49 |
| Oct 23, 2026 | OREN, ILAN | Director | Common Shares | Acquisition | 810 | $0 |
| Oct 20, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Disposal | 14,144 | $35.42 |
| Oct 20, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Disposal | 185,856 | $35.09 |
| Oct 16, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Disposal | 19,976 | $33.53 |
| Oct 16, 2026 | GLINE, MATTHEW | Director, CEO | Common Shares | Disposal | 34,638 | $33.53 |
| Oct 1, 2026 | EPPERLY, MELISSA B, | Director | Common Shares | Disposal | 16,850 | $36.08 |
| Oct 1, 2026 | EPPERLY, MELISSA B, | Director | Common Shares | Acquisition | 17,750 | $4.46 |
| Oct 1, 2026 | EPPERLY, MELISSA B, | Director | Stock Option (Right to Buy) | Acquisition | 17,750 | $0 |
| Oct 1, 2026 | ROIVANT, SCIENCES LTD. | Director, 10% Owner | Common Shares | Disposal | 8,967,383 | $5 |
| Oct 1, 2026 | EPPERLY, MELISSA B, | Director | Common Shares | Disposal | 900 | $36.57 |
| Sep 30, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Acquisition | 200,000 | $3.85 |
| Sep 30, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Disposal | 200,000 | $36.62 |
| Sep 30, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Disposal | 46,879 | $36.57 |
| Sep 30, 2026 | VENKER, ERIC | President & Immunovant CEO | Stock Option (Right to Buy) | Disposal | 200,000 | $0 |
| Sep 30, 2026 | GLINE, MATTHEW | Director, CEO | Common Shares | Disposal | 76,171 | $36.57 |
| Sep 30, 2026 | TORTI, FRANK | President and Vant Chair | Common Shares | Acquisition | 40,309 | $36.57 |
| Sep 30, 2026 | VENKER, ERIC | President & Immunovant CEO | Stock Option (Right to Buy) | Acquisition | 200,000 | $0 |
| Sep 30, 2026 | TORTI, FRANK | President and Vant Chair | Common Shares | Disposal | 40,309 | $36.57 |
| Sep 20, 2026 | PULIK, RICHARD | CFO | Common Shares | Disposal | 2,129 | $39.77 |
| Sep 20, 2026 | HUMES, JENNIFER | Chief Accounting Officer | Common Shares | Disposal | 3,880 | $39.77 |
| Sep 16, 2026 | MOMTAZEE, JAMES C | Director | Common Shares | Acquisition | 5,054 | $0 |
| Sep 16, 2026 | GOLD, DANIEL ALLEN | Director | Common Shares | Acquisition | 5,054 | $0 |
| Sep 16, 2026 | FITZGERALD, MEGHAN | Director | Stock Option (Right to Buy) | Acquisition | 10,531 | $0 |
| Sep 16, 2026 | MANCHESTER, KEITH S | Director | Stock Option (Right to Buy) | Acquisition | 10,531 | $0 |
| Sep 16, 2026 | OREN, ILAN | Director | Common Shares | Acquisition | 5,054 | $0 |
| Sep 16, 2026 | MOMTAZEE, JAMES C | Director | Stock Option (Right to Buy) | Acquisition | 10,531 | $0 |
| Sep 16, 2026 | EPPERLY, MELISSA B, | Director | Stock Option (Right to Buy) | Acquisition | 10,531 | $0 |
| Sep 16, 2026 | EPPERLY, MELISSA B, | Director | Common Shares | Acquisition | 5,054 | $0 |
| Sep 16, 2026 | GOLD, DANIEL ALLEN | Director | Stock Option (Right to Buy) | Acquisition | 10,531 | $0 |
| Sep 16, 2026 | OREN, ILAN | Director | Stock Option (Right to Buy) | Acquisition | 10,531 | $0 |
| Sep 16, 2026 | MANCHESTER, KEITH S | Director | Common Shares | Acquisition | 5,054 | $0 |
| Sep 16, 2026 | FITZGERALD, MEGHAN | Director | Common Shares | Acquisition | 5,054 | $0 |
| Sep 15, 2026 | EPPERLY, MELISSA B, | Director | Common Shares | Disposal | 600 | $40.38 |
| Sep 15, 2026 | FITZGERALD, MEGHAN | Director | Common Shares | Disposal | 400 | $40.45 |
| Sep 15, 2026 | FITZGERALD, MEGHAN | Director | Common Shares | Disposal | 4,712 | $39.68 |
| Sep 15, 2026 | EPPERLY, MELISSA B, | Director | Common Shares | Disposal | 4,338 | $39.65 |
| Sep 10, 2026 | EPPERLY, MELISSA B, | Director | Common Shares | Disposal | 2,179 | $40.94 |
| Sep 10, 2026 | OREN, ILAN | Director | Common Shares | Disposal | 2,378 | $40.94 |
| Sep 10, 2026 | MOMTAZEE, JAMES C | Director | Common Shares | Disposal | 2,905 | $40.94 |
| Sep 10, 2026 | FITZGERALD, MEGHAN | Director | Common Shares | Disposal | 1,743 | $40.94 |
| Sep 10, 2026 | GOLD, DANIEL ALLEN | Director | Common Shares | Disposal | 5,133 | $40.94 |
| Sep 8, 2026 | FITZGERALD, MEGHAN | Director | Common Shares | Acquisition | 20,000 | $8.80 |
| Sep 8, 2026 | FITZGERALD, MEGHAN | Director | Common Shares | Disposal | 20,000 | $39.90 |
| Sep 8, 2026 | FITZGERALD, MEGHAN | Director | Stock Option (Right to Buy) | Disposal | 20,000 | $0 |
| Sep 8, 2026 | FITZGERALD, MEGHAN | Director | Stock Option (Right to Buy) | Acquisition | 20,000 | $0 |
| Aug 28, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Disposal | 33,818 | $36.44 |
| Aug 28, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Acquisition | 200,000 | $3.85 |
| Aug 28, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Disposal | 166,182 | $35.63 |
| Aug 28, 2026 | VENKER, ERIC | President & Immunovant CEO | Stock Option (Right to Buy) | Disposal | 200,000 | $0 |
| Aug 28, 2026 | VENKER, ERIC | President & Immunovant CEO | Stock Option (Right to Buy) | Acquisition | 200,000 | $0 |
| Aug 21, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Stock Option (Right to Buy) | Disposal | 144,756 | $0 |
| Aug 21, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Disposal | 144,756 | $36.48 |
| Aug 21, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Acquisition | 144,756 | $3.85 |
| Aug 21, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Stock Option (Right to Buy) | Acquisition | 144,756 | $0 |
| Aug 20, 2026 | PULIK, RICHARD | CFO | Common Shares | Disposal | 5,749 | $36.84 |
| Aug 20, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Disposal | 13,909 | $36.84 |
| Aug 20, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Acquisition | 17,519 | $3.85 |
| Aug 20, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Disposal | 17,519 | $37.30 |
| Aug 20, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Stock Option (Right to Buy) | Disposal | 17,519 | $0 |
| Aug 20, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Stock Option (Right to Buy) | Acquisition | 17,519 | $0 |
| Aug 19, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Disposal | 172,899 | $37.17 |
| Aug 19, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Acquisition | 172,899 | $3.85 |
| Aug 19, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Stock Option (Right to Buy) | Disposal | 172,899 | $0 |
| Aug 19, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Stock Option (Right to Buy) | Acquisition | 172,899 | $0 |
| Aug 18, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Disposal | 105,141 | $36.59 |
| Aug 18, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Acquisition | 105,141 | $3.85 |
| Aug 18, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Acquisition | 31,801 | $3.85 |
| Aug 18, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Disposal | 136,942 | $0 |
| Aug 18, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Disposal | 31,801 | $37.18 |
| Aug 18, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Acquisition | 136,942 | $0 |
| Aug 17, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Disposal | 284,707 | $36.25 |
| Aug 17, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Acquisition | 284,707 | $0 |
| Aug 14, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Disposal | 243,177 | $36.23 |
| Aug 14, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Acquisition | 243,177 | $3.85 |
| Jul 27, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Acquisition | 200,000 | $3.85 |
| Jul 27, 2026 | VENKER, ERIC | President & Immunovant CEO | Stock Option (Right to Buy) | Disposal | 200,000 | $0 |
| Jul 27, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Disposal | 200,000 | $34.95 |
| Jul 27, 2026 | VENKER, ERIC | President & Immunovant CEO | Stock Option (Right to Buy) | Acquisition | 200,000 | $0 |
| Jul 17, 2026 | MOMTAZEE, JAMES C | Director | Common Shares | Acquisition | 405 | $0 |
| Jul 17, 2026 | EPPERLY, MELISSA B, | Director | Common Shares | Acquisition | 543 | $0 |
| Jul 17, 2026 | OREN, ILAN | Director | Common Shares | Acquisition | 775 | $0 |
| Jun 30, 2026 | MANCHESTER, KEITH S | Director | Common Shares | Disposal | 200,000 | $35.45 |
| Jun 30, 2026 | GOLD, DANIEL ALLEN | Director | Common Shares | Disposal | 12,380 | $35.28 |
| Jun 30, 2026 | QVT, FINANCIAL LP | Director by Deputization | Common Shares | Disposal | 12,380 | $35.28 |
| Jun 30, 2026 | FITZGERALD, MEGHAN | Director | Common Shares | Acquisition | 10,000 | $8.80 |
| Jun 30, 2026 | TORTI, FRANK | President and Vant Chair | Common Shares | Disposal | 40,310 | $35.39 |
| Jun 30, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Disposal | 46,878 | $35.39 |
| Jun 30, 2026 | GLINE, MATTHEW | Director, CEO | Common Shares | Disposal | 76,171 | $35.39 |
| Jun 30, 2026 | FITZGERALD, MEGHAN | Director | Common Shares | Disposal | 10,000 | $34.90 |
| Jun 30, 2026 | FITZGERALD, MEGHAN | Director | Stock Option (Right to Buy) | Disposal | 10,000 | $0 |
| Jun 30, 2026 | MANCHESTER, KEITH S | Director | Common Shares | Disposal | 12,380 | $35.28 |
| Jun 30, 2026 | FITZGERALD, MEGHAN | Director | Stock Option (Right to Buy) | Acquisition | 10,000 | $0 |
| Jun 29, 2026 | EPPERLY, MELISSA B, | Director | Common Shares | Disposal | 2,748 | $34.71 |
| Jun 29, 2026 | MANCHESTER, KEITH S | Director | Common Shares | Disposal | 200,000 | $34.44 |
| Jun 29, 2026 | GOLD, DANIEL ALLEN | Director | Common Shares | Disposal | 600,000 | $34.59 |
| Jun 29, 2026 | QVT, FINANCIAL LP | Director by Deputization | Common Shares | Disposal | 200,000 | $34.44 |
| Jun 29, 2026 | MANCHESTER, KEITH S | Director | Common Shares | Disposal | 600,000 | $34.59 |
| Jun 29, 2026 | EPPERLY, MELISSA B, | Director | Common Shares | Acquisition | 17,750 | $4.46 |
| Jun 29, 2026 | QVT, FINANCIAL LP | Director by Deputization | Common Shares | Disposal | 600,000 | $34.59 |
| Jun 29, 2026 | EPPERLY, MELISSA B, | Director | Common Shares | Disposal | 15,002 | $34.32 |
| Jun 29, 2026 | GOLD, DANIEL ALLEN | Director | Common Shares | Disposal | 200,000 | $34.44 |
| Jun 29, 2026 | EPPERLY, MELISSA B, | Director | Stock Option (Right to Buy) | Disposal | 17,750 | $0 |
| Jun 29, 2026 | EPPERLY, MELISSA B, | Director | Stock Option (Right to Buy) | Acquisition | 17,750 | $0 |
| Jun 26, 2026 | MANCHESTER, KEITH S | Director | Common Shares | Disposal | 325,000 | $34.07 |
| Jun 26, 2026 | QVT, FINANCIAL LP | Director by Deputization | Common Shares | Disposal | 300,783 | $33.92 |
| Jun 26, 2026 | GOLD, DANIEL ALLEN | Director | Common Shares | Disposal | 300,783 | $33.92 |
| Jun 26, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Stock Option (Right to Buy) | Disposal | 500,000 | $0 |
| Jun 26, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Disposal | 500,000 | $34.08 |
| Jun 26, 2026 | GOLD, DANIEL ALLEN | Director | Common Shares | Disposal | 325,000 | $34.07 |
| Jun 26, 2026 | QVT, FINANCIAL LP | Director by Deputization | Common Shares | Disposal | 325,000 | $34.07 |
| Jun 26, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Acquisition | 500,000 | $3.85 |
| Jun 26, 2026 | MANCHESTER, KEITH S | Director | Common Shares | Disposal | 300,783 | $33.92 |
| Jun 26, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Stock Option (Right to Buy) | Acquisition | 500,000 | $0 |
| Jun 25, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Disposal | 500,000 | $34.13 |
| Jun 25, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Acquisition | 500,000 | $3.85 |
| Jun 25, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Stock Option (Right to Buy) | Disposal | 500,000 | $0 |
| Jun 25, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Stock Option (Right to Buy) | Acquisition | 500,000 | $0 |
| Jun 24, 2026 | VENKER, ERIC | President & Immunovant CEO | Stock Option (Right to Buy) | Disposal | 200,000 | $0 |
| Jun 24, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Disposal | 46,234 | $33.51 |
| Jun 24, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Acquisition | 200,000 | $3.85 |
| Jun 24, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Disposal | 153,766 | $33.05 |
| Jun 24, 2026 | VENKER, ERIC | President & Immunovant CEO | Stock Option (Right to Buy) | Acquisition | 200,000 | $0 |
| Jun 20, 2026 | PULIK, RICHARD | CFO | Common Shares | Disposal | 2,129 | $31.43 |
| Jun 20, 2026 | HUMES, JENNIFER | Chief Accounting Officer | Common Shares | Disposal | 3,582 | $31.43 |
| May 22, 2026 | VENKER, ERIC | President & Immunovant CEO | Stock Option (Right to Buy) | Disposal | 200,000 | $0 |
| May 22, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Disposal | 200,000 | $30.27 |
| May 22, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Acquisition | 200,000 | $3.85 |
| May 22, 2026 | VENKER, ERIC | President & Immunovant CEO | Stock Option (Right to Buy) | Acquisition | 200,000 | $0 |
| May 20, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Disposal | 34,483 | $32.41 |
| May 20, 2026 | PULIK, RICHARD | CFO | Common Shares | Disposal | 18,962 | $32.41 |
| Apr 20, 2026 | VENKER, ERIC | President & Immunovant CEO | Stock Option (Right to Buy) | Disposal | 200,000 | $0 |
| Apr 20, 2026 | HUMES, JENNIFER | Chief Accounting Officer | Common Shares | Acquisition | 29,173 | $0 |
| Apr 20, 2026 | PULIK, RICHARD | CFO | Common Shares | Acquisition | 60,644 | $0 |
| Apr 20, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Acquisition | 200,000 | $3.85 |
| Apr 20, 2026 | HUMES, JENNIFER | Chief Accounting Officer | Stock Option (Right to Buy) | Acquisition | 27,157 | $0 |
| Apr 20, 2026 | PULIK, RICHARD | CFO | Stock Option (Right to Buy) | Acquisition | 84,026 | $0 |
| Apr 20, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Disposal | 200,000 | $29.59 |
| Apr 20, 2026 | VENKER, ERIC | President & Immunovant CEO | Stock Option (Right to Buy) | Acquisition | 200,000 | $0 |
| Apr 17, 2026 | OREN, ILAN | Director | Common Shares | Disposal | 95 | $29.83 |
| Apr 17, 2026 | OREN, ILAN | Director | Common Shares | Acquisition | 896 | $0 |
| Apr 17, 2026 | MOMTAZEE, JAMES C | Director | Common Shares | Disposal | 94 | $29.83 |
| Apr 17, 2026 | MOMTAZEE, JAMES C | Director | Common Shares | Acquisition | 469 | $0 |
| Apr 17, 2026 | EPPERLY, MELISSA B, | Director | Common Shares | Acquisition | 670 | $0 |
| Apr 16, 2026 | GLINE, MATTHEW | Director, CEO | Common Shares | Disposal | 289,774 | $29.16 |
| Apr 8, 2026 | HUMES, JENNIFER | Chief Accounting Officer | Common Shares | Disposal | 13,538 | $28.37 |
| Mar 31, 2026 | GLINE, MATTHEW | Director, CEO | Common Shares | Disposal | 304,684 | $27.70 |
| Mar 31, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Disposal | 187,512 | $27.70 |
| Mar 31, 2026 | TORTI, FRANK | President and Vant Chair | Common Shares | Disposal | 160,035 | $27.70 |
| Mar 30, 2026 | GLINE, MATTHEW | Director, CEO | Capped Value Appreciation Rights | Disposal | 2,178,150 | $11.50 |
| Mar 30, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Capped Value Appreciation Rights | Disposal | 1,306,889 | $11.50 |
| Mar 30, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Acquisition | 58,391 | n/a |
| Mar 30, 2026 | GLINE, MATTHEW | Director, CEO | Common Shares | Disposal | 53,826 | $26.41 |
| Mar 30, 2026 | GLINE, MATTHEW | Director, CEO | Common Shares | Acquisition | 97,319 | n/a |
| Mar 30, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Disposal | 29,809 | $26.41 |
| Mar 30, 2026 | GLINE, MATTHEW | Director, CEO | Capped Value Appreciation Rights | Acquisition | 2,178,150 | $11.50 |
| Mar 30, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Capped Value Appreciation Rights | Acquisition | 1,306,889 | $11.50 |
| Mar 26, 2026 | FITZGERALD, MEGHAN | Director | Common Shares | Acquisition | 70,000 | $8.80 |
| Mar 26, 2026 | FITZGERALD, MEGHAN | Director | Stock Option (Right to Buy) | Disposal | 70,000 | $0 |
| Mar 26, 2026 | FITZGERALD, MEGHAN | Director | Common Shares | Disposal | 70,000 | $27.45 |
| Mar 26, 2026 | FITZGERALD, MEGHAN | Director | Stock Option (Right to Buy) | Acquisition | 70,000 | $0 |
| Mar 20, 2026 | PULIK, RICHARD | CFO | Common Shares | Disposal | 1,546 | $27.70 |
| Mar 20, 2026 | HUMES, JENNIFER | Chief Accounting Officer | Common Shares | Disposal | 14,526 | $27.70 |
| Mar 17, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Acquisition | 200,000 | $3.85 |
| Mar 17, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Disposal | 200,000 | $28.24 |
| Mar 17, 2026 | VENKER, ERIC | President & Immunovant CEO | Stock Option (Right to Buy) | Disposal | 200,000 | $0 |
| Mar 17, 2026 | VENKER, ERIC | President & Immunovant CEO | Stock Option (Right to Buy) | Acquisition | 200,000 | $0 |
| Mar 16, 2026 | EPPERLY, MELISSA B, | Director | Common Shares | Disposal | 41,861 | $28.68 |
| Feb 23, 2026 | TORTI, FRANK | President and Vant Chair | Stock Option (Right to Buy) | Disposal | 587,390 | $0 |
| Feb 23, 2026 | TORTI, FRANK | President and Vant Chair | Common Shares | Disposal | 587,390 | $27.51 |
| Feb 23, 2026 | TORTI, FRANK | President and Vant Chair | Common Shares | Acquisition | 587,390 | $3.85 |
| Feb 23, 2026 | TORTI, FRANK | President and Vant Chair | Stock Option (Right to Buy) | Acquisition | 587,390 | $0 |
| Feb 20, 2026 | TORTI, FRANK | President and Vant Chair | Common Shares | Acquisition | 1,012,610 | $3.85 |
| Feb 20, 2026 | TORTI, FRANK | President and Vant Chair | Common Shares | Disposal | 1,012,610 | $27.15 |
| Feb 20, 2026 | TORTI, FRANK | President and Vant Chair | Stock Option (Right to Buy) | Disposal | 1,012,610 | $0 |
| Feb 20, 2026 | PULIK, RICHARD | CFO | Common Shares | Disposal | 1,000 | $27.15 |
| Feb 20, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Disposal | 7,051 | $27.15 |
| Feb 20, 2026 | TORTI, FRANK | President and Vant Chair | Stock Option (Right to Buy) | Acquisition | 1,012,610 | $0 |
| Feb 19, 2026 | TORTI, FRANK | President and Vant Chair | Common Shares | Acquisition | 1,400,000 | $3.85 |
| Feb 19, 2026 | TORTI, FRANK | President and Vant Chair | Common Shares | Disposal | 1,400,000 | $27.42 |
| Feb 19, 2026 | TORTI, FRANK | President and Vant Chair | Stock Option (Right to Buy) | Disposal | 1,400,000 | $0 |
| Feb 19, 2026 | TORTI, FRANK | President and Vant Chair | Stock Option (Right to Buy) | Acquisition | 1,400,000 | $0 |
| Feb 13, 2026 | MANCHESTER, KEITH S | Director | Common Shares | Disposal | 150,784 | $26.49 |
| Feb 13, 2026 | MANCHESTER, KEITH S | Director | Common Shares | Disposal | 225,000 | $26.50 |
| Feb 13, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Acquisition | 200,000 | $3.85 |
| Feb 13, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Disposal | 200,000 | $26.49 |
| Feb 13, 2026 | QVT, FINANCIAL LP | Director by Deputization | Common Shares | Disposal | 150,784 | $26.49 |
| Feb 13, 2026 | QVT, FINANCIAL LP | Director by Deputization | Common Shares | Disposal | 225,000 | $26.50 |
| Feb 13, 2026 | GOLD, DANIEL ALLEN | Director | Common Shares | Disposal | 225,000 | $26.50 |
| Feb 13, 2026 | GOLD, DANIEL ALLEN | Director | Common Shares | Disposal | 150,784 | $26.49 |
| Feb 13, 2026 | VENKER, ERIC | President & Immunovant CEO | Stock Option (Right to Buy) | Disposal | 200,000 | $0 |
| Feb 13, 2026 | VENKER, ERIC | President & Immunovant CEO | Stock Option (Right to Buy) | Acquisition | 200,000 | $0 |
| Feb 12, 2026 | MANCHESTER, KEITH S | Director | Common Shares | Disposal | 150,000 | $26.72 |
| Feb 12, 2026 | MANCHESTER, KEITH S | Director | Common Shares | Disposal | 275,000 | $26.76 |
| Feb 12, 2026 | GOLD, DANIEL ALLEN | Director | Common Shares | Disposal | 275,000 | $26.76 |
| Feb 12, 2026 | QVT, FINANCIAL LP | Director by Deputization | Common Shares | Disposal | 150,000 | $26.72 |
| Feb 12, 2026 | GOLD, DANIEL ALLEN | Director | Common Shares | Disposal | 150,000 | $26.72 |
| Feb 12, 2026 | QVT, FINANCIAL LP | Director by Deputization | Common Shares | Disposal | 275,000 | $26.76 |
| Feb 11, 2026 | MANCHESTER, KEITH S | Director | Common Shares | Disposal | 425,000 | $26.67 |
| Feb 11, 2026 | GOLD, DANIEL ALLEN | Director | Common Shares | Disposal | 425,000 | $26.67 |
| Feb 11, 2026 | QVT, FINANCIAL LP | Director by Deputization | Common Shares | Disposal | 425,000 | $26.67 |
| Feb 9, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Stock Option (Right to Buy) | Disposal | 651,558 | $0 |
| Feb 9, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Disposal | 339,441 | $26.47 |
| Feb 9, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Disposal | 312,117 | $26.47 |
| Feb 9, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Acquisition | 651,558 | $12.68 |
| Feb 9, 2026 | SUKHATME, MAYUKH | Director, President & CIO | Stock Option (Right to Buy) | Acquisition | 651,558 | $0 |
| Jan 20, 2026 | OREN, ILAN | Director | Common Shares | Acquisition | 1,164 | $0 |
| Jan 20, 2026 | EPPERLY, MELISSA B, | Director | Common Shares | Disposal | 54 | $22.98 |
| Jan 20, 2026 | MOMTAZEE, JAMES C | Director | Common Shares | Disposal | 122 | $22.98 |
| Jan 20, 2026 | MOMTAZEE, JAMES C | Director | Common Shares | Acquisition | 609 | $0 |
| Jan 20, 2026 | EPPERLY, MELISSA B, | Director | Common Shares | Acquisition | 815 | $0 |
| Jan 20, 2026 | OREN, ILAN | Director | Common Shares | Disposal | 124 | $22.98 |
| Jan 12, 2026 | VENKER, ERIC | President & Immunovant CEO | Stock Option (Right to Buy) | Disposal | 200,000 | $0 |
| Jan 12, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Acquisition | 200,000 | $3.85 |
| Jan 12, 2026 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Disposal | 200,000 | $21.92 |
| Jan 12, 2026 | VENKER, ERIC | President & Immunovant CEO | Stock Option (Right to Buy) | Acquisition | 200,000 | $0 |
| Dec 31, 2025 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Disposal | 1,430,882 | $21.71 |
| Dec 31, 2025 | SUKHATME, MAYUKH | Director, President & CIO | Stock Option (Right to Buy) | Disposal | 2,449,877 | $0 |
| Dec 31, 2025 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Disposal | 1,018,995 | $21.71 |
| Dec 31, 2025 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Acquisition | 2,449,877 | $12.68 |
| Dec 31, 2025 | SUKHATME, MAYUKH | Director, President & CIO | Stock Option (Right to Buy) | Acquisition | 2,449,877 | $0 |
| Dec 29, 2025 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Acquisition | 748,358 | $12.68 |
| Dec 29, 2025 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Disposal | 436,485 | $21.74 |
| Dec 29, 2025 | SUKHATME, MAYUKH | Director, President & CIO | Stock Option (Right to Buy) | Disposal | 748,358 | $0 |
| Dec 29, 2025 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Disposal | 311,873 | $21.74 |
| Dec 29, 2025 | SUKHATME, MAYUKH | Director, President & CIO | Stock Option (Right to Buy) | Acquisition | 748,358 | $0 |
| Dec 24, 2025 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Acquisition | 117,848 | $3.85 |
| Dec 24, 2025 | VENKER, ERIC | President & Immunovant CEO | Stock Option (Right to Buy) | Disposal | 117,848 | $0 |
| Dec 24, 2025 | TORTI, FRANK | President and Vant Chair | Common Shares | Disposal | 110,489 | $0 |
| Dec 24, 2025 | TORTI, FRANK | President and Vant Chair | Common Shares | Disposal | 64,891 | $22.47 |
| Dec 24, 2025 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Disposal | 75,000 | $22.53 |
| Dec 24, 2025 | VENKER, ERIC | President & Immunovant CEO | Stock Option (Right to Buy) | Acquisition | 117,848 | $0 |
| Dec 23, 2025 | PULIK, RICHARD | CFO | Common Shares | Disposal | 146,731 | $22.39 |
| Dec 23, 2025 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Disposal | 200,000 | $22.45 |
| Dec 23, 2025 | PULIK, RICHARD | CFO | Stock Option (Right to Buy) | Disposal | 260,000 | $0 |
| Dec 23, 2025 | PULIK, RICHARD | CFO | Common Shares | Disposal | 260,000 | $22.45 |
| Dec 23, 2025 | TORTI, FRANK | President and Vant Chair | Common Shares | Acquisition | 175,380 | $22.45 |
| Dec 23, 2025 | VENKER, ERIC | President & Immunovant CEO | Stock Option (Right to Buy) | Disposal | 313,841 | $0 |
| Dec 23, 2025 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Acquisition | 313,841 | $3.85 |
| Dec 23, 2025 | PULIK, RICHARD | CFO | Common Shares | Acquisition | 260,000 | $3.85 |
| Dec 23, 2025 | PULIK, RICHARD | CFO | Stock Option (Right to Buy) | Acquisition | 260,000 | $0 |
| Dec 23, 2025 | VENKER, ERIC | President & Immunovant CEO | Stock Option (Right to Buy) | Acquisition | 313,841 | $0 |
| Dec 20, 2025 | PULIK, RICHARD | CFO | Common Shares | Disposal | 2,129 | $22.41 |
| Dec 17, 2025 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Disposal | 59,513 | $0 |
| Dec 17, 2025 | QVT, FINANCIAL LP | Director by Deputization | Common Shares | Disposal | 155,076 | $23.02 |
| Dec 17, 2025 | MANCHESTER, KEITH S | Director | Common Shares | Disposal | 189,538 | $23.17 |
| Dec 17, 2025 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Acquisition | 59,513 | $0 |
| Dec 17, 2025 | GOLD, DANIEL ALLEN | Director | Common Shares | Disposal | 432,718 | $23.05 |
| Dec 17, 2025 | QVT, FINANCIAL LP | Director by Deputization | Common Shares | Disposal | 432,718 | $23.05 |
| Dec 17, 2025 | MANCHESTER, KEITH S | Director | Common Shares | Disposal | 155,076 | $23.02 |
| Dec 17, 2025 | GOLD, DANIEL ALLEN | Director | Common Shares | Disposal | 189,538 | $23.17 |
| Dec 17, 2025 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Disposal | 32,682 | $23.09 |
| Dec 17, 2025 | QVT, FINANCIAL LP | Director by Deputization | Common Shares | Disposal | 189,538 | $23.17 |
| Dec 17, 2025 | SUKHATME, MAYUKH | Director, President & CIO | Common Shares | Disposal | 26,831 | $23.09 |
| Dec 17, 2025 | MANCHESTER, KEITH S | Director | Common Shares | Disposal | 432,718 | $23.05 |
| Dec 17, 2025 | GOLD, DANIEL ALLEN | Director | Common Shares | Disposal | 155,076 | $23.02 |
| Dec 16, 2025 | MANCHESTER, KEITH S | Director | Common Shares | Disposal | 642,282 | $23.08 |
| Dec 16, 2025 | GOLD, DANIEL ALLEN | Director | Common Shares | Disposal | 275,000 | $22.93 |
| Dec 16, 2025 | QVT, FINANCIAL LP | Director by Deputization | Common Shares | Disposal | 275,000 | $22.93 |
| Dec 16, 2025 | GOLD, DANIEL ALLEN | Director | Common Shares | Disposal | 642,282 | $23.08 |
| Dec 16, 2025 | QVT, FINANCIAL LP | Director by Deputization | Common Shares | Disposal | 642,282 | $23.08 |
| Dec 16, 2025 | MANCHESTER, KEITH S | Director | Common Shares | Disposal | 275,000 | $22.93 |
| Dec 15, 2025 | GLINE, MATTHEW | Director, CEO | Common Shares | Acquisition | 234,096 | $4.06 |
| Dec 15, 2025 | RAMASWAMY, VIVEK | 10% Owner | Common Shares | Acquisition | 832,453 | $12.68 |
| Dec 15, 2025 | RAMASWAMY, VIVEK | 10% Owner | Common Shares | Disposal | 353,745 | $22.05 |
| Dec 15, 2025 | GLINE, MATTHEW | Director, CEO | Common Shares | Disposal | 943,527 | $21.68 |
| Dec 15, 2025 | GLINE, MATTHEW | Director, CEO | Common Shares | Disposal | 1,329,325 | $21.68 |
| Dec 15, 2025 | RAMASWAMY, VIVEK | 10% Owner | Stock Option (Right to Buy) | Disposal | 832,453 | $0 |
| Dec 15, 2025 | GLINE, MATTHEW | Director, CEO | Stock Option (Right to Buy) | Disposal | 234,096 | $0 |
| Dec 15, 2025 | GLINE, MATTHEW | Director, CEO | Common Shares | Disposal | 230,357 | $21.68 |
| Dec 15, 2025 | GLINE, MATTHEW | Director, CEO | Common Shares | Acquisition | 1,363,711 | $12.68 |
| Dec 15, 2025 | GLINE, MATTHEW | Director, CEO | Common Shares | Disposal | 566,116 | $21.68 |
| Dec 15, 2025 | GLINE, MATTHEW | Director, CEO | Common Shares | Acquisition | 2,272,852 | $12.68 |
| Dec 15, 2025 | GLINE, MATTHEW | Director, CEO | Common Shares | Disposal | 797,595 | $21.68 |
| Dec 15, 2025 | RAMASWAMY, VIVEK | 10% Owner | Common Shares | Disposal | 478,708 | $22.05 |
| Dec 15, 2025 | GLINE, MATTHEW | Director, CEO | Stock Option (Right to Buy) | Disposal | 1,363,711 | $0 |
| Dec 15, 2025 | GLINE, MATTHEW | Director, CEO | Stock Option (Right to Buy) | Disposal | 2,272,852 | $0 |
| Dec 15, 2025 | GLINE, MATTHEW | Director, CEO | Common Shares | Disposal | 3,739 | $21.68 |
| Dec 15, 2025 | RAMASWAMY, VIVEK | 10% Owner | Stock Option (Right to Buy) | Acquisition | 832,453 | $0 |
| Dec 15, 2025 | GLINE, MATTHEW | Director, CEO | Stock Option (Right to Buy) | Acquisition | 234,096 | $0 |
| Dec 15, 2025 | GLINE, MATTHEW | Director, CEO | Stock Option (Right to Buy) | Acquisition | 2,272,852 | $0 |
| Dec 15, 2025 | GLINE, MATTHEW | Director, CEO | Stock Option (Right to Buy) | Acquisition | 1,363,711 | $0 |
| Dec 12, 2025 | RAMASWAMY, VIVEK | 10% Owner | Stock Option (Right to Buy) | Disposal | 4,672,724 | $0 |
| Dec 12, 2025 | RAMASWAMY, VIVEK | 10% Owner | Common Shares | Acquisition | 4,672,724 | $12.68 |
| Dec 12, 2025 | RAMASWAMY, VIVEK | 10% Owner | Common Shares | Disposal | 2,696,866 | $21.96 |
| Dec 12, 2025 | RAMASWAMY, VIVEK | 10% Owner | Common Shares | Disposal | 1,975,858 | $21.96 |
| Dec 12, 2025 | ROIVANT, SCIENCES LTD. | Director, 10% Owner | Common Stock, $0.0001 par value per share | Acquisition | 16,666,666 | $21 |
| Dec 12, 2025 | RAMASWAMY, VIVEK | 10% Owner | Stock Option (Right to Buy) | Acquisition | 4,672,724 | $0 |
| Dec 11, 2025 | RAMASWAMY, VIVEK | 10% Owner | Common Shares | Disposal | 1,095,550 | $21.64 |
| Dec 11, 2025 | RAMASWAMY, VIVEK | 10% Owner | Common Shares | Disposal | 774,142 | $21.64 |
| Dec 11, 2025 | RAMASWAMY, VIVEK | 10% Owner | Stock Option (Right to Buy) | Disposal | 1,869,691 | $0 |
| Dec 11, 2025 | RAMASWAMY, VIVEK | 10% Owner | Common Shares | Acquisition | 1,869,691 | $12.68 |
| Dec 11, 2025 | RAMASWAMY, VIVEK | 10% Owner | Stock Option (Right to Buy) | Acquisition | 1,869,691 | $0 |
| Dec 9, 2025 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Acquisition | 200,000 | $3.85 |
| Dec 9, 2025 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Disposal | 200,000 | $20.85 |
| Dec 9, 2025 | VENKER, ERIC | President & Immunovant CEO | Stock Option (Right to Buy) | Disposal | 200,000 | $0 |
| Dec 9, 2025 | VENKER, ERIC | President & Immunovant CEO | Stock Option (Right to Buy) | Acquisition | 200,000 | $0 |
| Nov 20, 2025 | PULIK, RICHARD | CFO | Common Shares | Disposal | 1,235 | $20.27 |
| Nov 20, 2025 | VENKER, ERIC | President & Immunovant CEO | Common Shares | Disposal | 7,051 | $20.27 |
| Nov 19, 2025 | MANCHESTER, KEITH S | Director | Common Shares | Disposal | 150,000 | $20.20 |
| Nov 19, 2025 | QVT, FINANCIAL LP | Director by Deputization | Common Shares | Disposal | 175,000 | $20.24 |
| Nov 19, 2025 | GOLD, DANIEL ALLEN | Director | Common Shares | Disposal | 175,000 | $20.24 |
| Nov 19, 2025 | MANCHESTER, KEITH S | Director | Common Shares | Disposal | 850,000 | $20.25 |
| Nov 19, 2025 | GOLD, DANIEL ALLEN | Director | Common Shares | Disposal | 125,000 | $20.16 |
| Nov 19, 2025 | QVT, FINANCIAL LP | Director by Deputization | Common Shares | Disposal | 125,000 | $20.16 |
| Nov 19, 2025 | GOLD, DANIEL ALLEN | Director | Common Shares | Disposal | 150,000 | $20.20 |
| Nov 19, 2025 | QVT, FINANCIAL LP | Director by Deputization | Common Shares | Disposal | 150,000 | $20.20 |
| Nov 19, 2025 | MANCHESTER, KEITH S | Director | Common Shares | Disposal | 175,000 | $20.24 |
| Nov 19, 2025 | QVT, FINANCIAL LP | Director by Deputization | Common Shares | Disposal | 850,000 | $20.25 |
| Nov 19, 2025 | GOLD, DANIEL ALLEN | Director | Common Shares | Disposal | 850,000 | $20.25 |
| Nov 19, 2025 | MANCHESTER, KEITH S | Director | Common Shares | Disposal | 125,000 | $20.16 |
| Nov 17, 2025 | RAMASWAMY, VIVEK | 10% Owner | Common Shares | Disposal | 539,650 | $20.51 |
| Nov 14, 2025 | RAMASWAMY, VIVEK | 10% Owner | Common Shares | Disposal | 1,027,670 | $20.33 |